Rise in the total AAUM which derived increase in commissions income; revenue from operations increased by 30% to Rs 333.24 crore in Q1FY22 as against Rs 256.62 crore for Q1FY21. However, when FY21 as compared to FY20, total revenues are reduced by 2.34% to Rs 1205.84 crore in FY21 from Rs 1233.84 crore. This was due to the decrease in total AAUM mainly driven by market volatility in the mutual fund industry in India due to loss of investor sentiment during the current COVID-19 pandemic. PAT showed an increasing trend for all the three fiscals as seen from the financial table below. PAT has been increasing despite the fall in AAUM due to a decrease in the prepaid commission expenses as a result of the trailing effect of the 2018 SEBI Circular as well as lower commission expenses incurred in connection with portfolio management services in line with a decrease in portfolio management services AAUM.
|Cash and Bank||52.04||56.56||46.63||38.25|
|Cash generated from operations||204.76||663.22||667.37||543.59|
With annualised EPS of 21.52, the issue is priced at 33x of its upper price band of Rs 712 per share. The industry average P/E is 39.84x indicating a reasonable valuation of the IPO. P/BV is 11.38x with a NAV of Rs 62.57 as of 30th June 2021.
The listed peers of the Issuer are HDFC AMC, Nippon Life AMC, and UTI AMC. SBI Life AMC and ICICI Prudential AMC MF are other large unlisted peers. The Peer Comparison table can be seen below.
|Particulars||HDFC AMC||Nippon Life AMC||UTI AMC||ABSL AMC|
|Face value per share||5||10||10||5|
|Revenues for FY21 (INR Crores)||2201.74||1419.34||1198.63||1205.84|
|NAV per share||224.28||50.29||255.31||59.19|
|Return on net worth||27.76%||21.94%||15.27%||30.87%|
Aggregate industry AUM grew 39.2% post-COVID-19 to Rs 33.7 trillion as of June 2021 from Rs 22.3 trillion as of March 2020, driven by recovery post the pandemic, increased B-30 penetration, and rising popularity of SIPs as an investment vehicle. AMC industry has seen robust growth, especially in recent years, driven by a growing investor base due to increasing penetration across geographies, strong growth of capital markets, technological progress, and regulations to make mutual fund products more transparent and investor-friendly.
ABSL AMC has maintained a market-leading position in B-30 penetration over the years which contributed to the growth of the individual investor base as well as improvement in profitability. Its share of MAAUM from B-30 cities in total MAAUM increased from 13.44% as of March 31, 2019, to 15.76% as of June 30, 2021. Also, all the listed AMC’s have shown good performance and given good returns to the investors as seen in the table (returns given by listed AMC’s). Hence, one may subscribe to the Issue.
|Listed AMCs||Listing year||Issue Price||Listing Price||CMP||Listing gains/loss||XIRR|
|Nippon Life AMC||Oct-17||252||296||437||17.42%||14.80%|
Review By CA Priyanka Choudhary on 8th Sep 2021
About CA Priyanka Choudhary
Priyanka Choudhary Jain is a Chartered Accountant and an experienced credit analyst. She has worked with CRISIL as Senior Credit Analyst on ratings assignments including business and financial analysis in Corporates as well as the Public Finance Sector.
Email: [email protected]
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published here. Any reader taking decisions based on any information published here does so entirely at own risk. Investors should bear in mind that any investment in stock markets are subject to unpredictable market related risks. Above information is based on RHP and other documents available as of date coupled with market perception. Author has no plans to invest in this offer.
No feedback found for this broker. Be the first to post the review.